Apatinib and Impurities
Ref: 4Z-A-367002
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 4Z-A-367001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 4Z-A-367003
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Apatinib-d8 25-N-Oxide Dihydrochloride
Controlled ProductCAS:1376710-40-5
Applications Labelled Apatinib 25-N-Oxide (A726160). Apatinib 25-N-Oxide is a metabolite of the antiangiogenic agent and …
Formula:
C24H15D8N5O2HCl
Color and Shape:
Neat
Molecular weight:
421.5223646
Ref: TR-A726162
| 1mg | 315.00 € | ||
| 10mg | 2,039.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
Apatinib
Controlled ProductCAS:811803-05-1
Applications Apatinib is an orally available, small molecule multitargeted tyrosine kinase inhibitor. Apatinib selectively inhibits …
Formula:
C24H23N5O·CH4O3S
Color and Shape:
Neat
Molecular weight:
493.58
Ref: TR-A726150
| 25mg | 281.00 € | ||
| 100mg | 1,176.00 € | ||
| 250mg | 1,825.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
